JPMorgan analyst Anne Samuel lowered the firm’s price target on Omnicell (OMCL) to $36 from $44 and keeps a Neutral rating on the shares. While ...

Omnicell (OMCL) announced that Nchacha Etta will be stepping down from his role as executive VP and CFO, effective September 15 or until a ...

The chief financial officer of Omnicell plans to step down sometime this year. The maker of automated medication-management systems said Wednesday that Nchacha Etta intends to depart on Sept.

Omnicell (OMCL) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of ...

Omnicell, Inc. engages in the provision of medication management automation solutions and adherence tools for healthcare systems and pharmacies. Its solutions include intelligence, platform and ...

FORT WORTH, Texas, March 12, 2025--(BUSINESS WIRE)--Omnicell, Inc. (NASDAQ:OMCL) ("Omnicell," "we," "our," "us," "management," or the "Company"), a leader in ...

Omnicell, Inc. has a 52 week low of $25.12 and a 52 week high of $55.74. The stock has a 50 day moving average price of $42.39 and a two-hundred day moving average price of $43.80. The stock has a ...